Hospital Sao Lucas da Pontificia Universidade Catolica do Rio Grande do Sul - PUC-RS

Porto Alegre 90610-001

1 studies enrolling now · 4 studies all time

What they study most

Chronic Spontaneous Urticaria, Colorectal Cancer, Locally Recurrent Breast Cancer, Metastatic Breast Cancer, Metastatic HER2-positive Breast Cancer, Neoplasms, Colorectal

Studies at this site

• A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer — Recruiting now
• A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria — Running, not enrolling
• Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer — Stopped early
• Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy — Completed